Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Yoav Benjamini, Yosef Hochberg · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1995 · 108.7K citations

Natural Sciences, Biostatistics, A/b Testing +13

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Roland R. Griffiths, Matthew W. Johnson, Michael A. Carducci et al. · Journal of Psychopharmacology · 2016 · 2.2K citations · Full text

Medicine, Oncology, Pharmacology +10

Predicting new molecular targets for known drugs

Michael J. Keiser, Vincent Setola, John J. Irwin et al. · Nature · 2009 · 1.7K citations

Pharmacy, Bioinformatics, Pharmacology +12

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Robin Carhart‐Harris, Mark Bolstridge, James Rucker et al. · The Lancet Psychiatry · 2016 · 1.5K citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +15

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

Alan K. Davis, Frederick S. Barrett, Darrick G. May et al. · JAMA Psychiatry · 2020 · 1.3K citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +13